A comparison of outcomes between OKT3 and antithymocyte globulin for treatment of steroid-resistant rejection in hepatitis C liver transplant recipients.
第一作者:
Mina M,Benjamin
第一单位:
1 Internal Medicine Department, Baylor University Medical Center, Dallas, TX. 2 Division of Gastroenterology, Internal Medicine Department, Baylor University Medical Center, Dallas, TX. 3 Address correspondence to: Mina M. Benjamin, M.D., Internal Medicine Department, Baylor University Medical Center, 3500 Gaston Avenue, Dallas, TX 75246.
作者:
主题词
成年人(Adult);老年人(Aged);抗淋巴细胞血清(Antilymphocyte Serum);活组织检查(Biopsy);女(雌)性(Female);移植物排斥(Graft Rejection);移植物存活(Graft Survival);丙型肝炎(Hepatitis C);人类(Humans);免疫抑制剂(Immunosuppressive Agents);肝(Liver);肝移植(Liver Transplantation);男(雄)性(Male);中年人(Middle Aged);莫罗单抗CD3(Muromonab-CD3);复发(Recurrence);回顾性研究(Retrospective Studies);甾类(Steroids);治疗结果(Treatment Outcome)
DOI
10.1097/01.TP.0000435701.54019.98
PMID
24142032
发布时间
2014-02-19
- 浏览16

Transplantation
470-3页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文